FDA warns of chondrolysis with continuously infused local anesthetics
The FDA has notified healthcare professionals of 35 reports of chondrolysis in patients given continuous intra-articular infusions of local anesthetics (eg, bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine, ropivacaine) with elastomeric infusion devices to control post-surgical pain.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.